Kriya Therapeutics, Inc. · 19 hours ago
Associate Director, Analytical Development (Protein-Based)
Triangle, NC
Full-time
Onsite
Lead/Staff, Director/Executive
5+ years expKriya Therapeutics, Inc. is a biopharmaceutical company focused on developing life-changing gene therapies. The Associate Director, Analytical Development will lead the characterization and development of analytical methods for AAV gene therapy vectors, while managing a team to support late-phase programs.
BiotechnologyHealth CareLife ScienceNeuroscience
Responsibilities
Lead a team tasked with developing analytical strategy for protein- and HPLC-based AAV gene therapy vector release and characterization
Contribute to science-driven, phase appropriate, and risk-based analytical development and specification setting to support all programs in the company
Serve as a subject matter expert and author and/or review relevant sections of documentation in support of INDs and other regulatory submissions
Seek out and analyze data from a variety of sources to support decisions
Make sound decisions regarding complex technical issues and communicate decisions effectively with internal stakeholders, elevating complex issues as appropriate
Lead and supervise the team technically to stay up-to-date and ensure high quality analytical capability
Coordinate sample plans cross-functionally to support phase appropriate development
Qualification
Required
PhD degree in Science, Biotechnology, Engineering or other related field and 5 years of industry experience, Master's degree and 8 years of experience, or Bachelor's degree and 10 years of experience
Demonstrate in-depth experience of the development, qualification, and implementation of analytical methods for the characterization and release testing of AAV vectors or biologic products in an industry setting
Sound understanding and demonstrated application of statistical methods/tools
Strong verbal, written, and interpersonal communication skills
Self-motivated, organized, capable of working independently and in a collaborative environment
Exercise of discretion and independent judgment
Ability and desire to work in a fast paced, startup environment
An ability to build effective relationships and work cross-functionally to deliver results and meet business objectives
Preferred
PhD preferred
Experience with analytical techniques including Chromatography, ELISA, Capillary Electrophoresis strongly preferred
Relevant AAV gene therapy experience in leading analytical development is preferred
Previous experience managing, coaching, and providing direction to technical staff in an industry setting is preferred
Experience with characterization and release testing of viral vector-based systems, plasmid DNA, or RNA products a plus
Late-stage method development and regulatory experience a plus
Benefits
Flexible Time Off
Paid Parental & Medical Leave
Paid Company Holidays
Fertility & Family Building Benefits
Medical, Dental, and Vision Insurance
Employee Assistance Program (EAP)
Life Insurance
Short- and Long-Term Disability Coverage
Equity
401(k) with Company Match
Identity Theft Protection
Company
Kriya Therapeutics, Inc.
Our mission is to revolutionize medicine, with the ultimate goal of eliminating human suffering and enabling people to live without the burden of disease.
51-200 employees
H1B Sponsorship
Kriya Therapeutics, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2023 (1)
2022 (3)
Funding
Current Stage
Late StageTotal Funding
$921.32MKey Investors
Patient Square CapitalQVT FinancialTranshuman Capital
2025-08-15Series D· $320.82M
2023-07-26Series C· $150M
2022-05-16Series C· $270M
Leadership Team
Shankar Ramaswamy
Co-Founder and Chief Executive Officer
Sachiyo Minegishi
Chief Financial Officer
Recent News
2026-01-05
Kriya Therapeutics, Inc.
2025-12-01
Company data provided by crunchbase